Taken together, our data suggest that the increased serum NGAL may be a sensitive marker in response to acute renal injury after stroke, which can be valuable as a complementary and alternative biomarker for predicting and diagnosis of AKI following stroke. The gene discussed is LCN2; the disease is acute kidney injury.